(ShareCast News) - Vectura´s full-year results edged past forecasts with analysts noting the sharp improvement in its free-cash-flow generation even as they pointed out several potential share price drivers which were looming increasingly closer on the horizon. The manufacturer of airways diseases t
Read more(ShareCast News) - Vectura Group said it was joining forces with Propeller Health to develop inhalers that combine their two technologies. In a statement, Vectura said the plan was to use its dry powder inhaler technology with Propeller's FDA-cleared digital health platform to treat respiratory dise
Read more(ShareCast News) - A respiratory treatment being developed using Vectura's Fox nebuliser technology device has passed safety and efficacy trials and looks likely to be moved into a Phase II efficacy study in infants. Drug developer Ablynx has published positive results from first-in-infant Phase I/I
Read more